BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
Advanced Therapies Week 2026
February 9 - February 12
Advanced Therapies Week 2026 brings together more than 2,000 leaders from biotech, investment, science, manufacturing, and regulation to accelerate translation and scale advanced therapies. This year’s program features deep content, high-impact networking, and expanded opportunities to connect across the ecosystem.
ARMI Participation
ARMI is actively engaged in the ATW26 program with senior leadership contributing to key sessions:
- Dr. Jen MacDonald, Chief Operating Officer — Session Chair, Automation & Advanced Manufacturing
- Dr. Richard McFarland, Chief Regulatory Officer — Session Chair, Commercial Models & Partnerships
These sessions focus on scalable manufacturing pathways and models for commercial success in cell and gene therapies.
ARMI Member Networking
ARMI will host an ARMI Member Mixer during the week to support connections between members, industry partners, and ecosystem leaders. If you are a member of ARMI and would like to attend please email outreach_membership@armiusa.org.
Member Registration Discount
ARMI members are encouraged to attend and engage with peers shaping the future of regenerative medicine and biofabrication. Members can receive a 20% discount on conference registration using code ARMI20.
For questions about attendance, scheduling meetings, or maximizing your time in San Diego, contact outreach_membership@armiusa.org.
For full event details and registration, visit: https://www.phacilitate.com/advanced-therapies-week.
